Rubra Medicaments Ltd.
BSE: 531099 | Sector: Others |
NSE: N.A. | ISIN Code: INE396H01019 |
BSE 00:00 | 25 Apr | 4.30 |
0 (0.00%) |
OPEN
4.52 |
HIGH
4.52 |
LOW
4.30 |
NSE 05:30 | 01 Jan | Rubra Medicaments Ltd |
OPEN | 4.52 |
PREVIOUS CLOSE | 4.30 |
VOLUME | 2858 |
52-Week high | 4.52 |
52-Week low | 2.27 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Rubra Medicaments Ltd. (RUBRAMEDICAMENT) - BULK DEALS
DATE | CLIENT NAME | EXCHANGE | TRANSACTION | QUANTITY | PRICE |
21-07-2017 | TULSA NETRAPRASHAD SILWAL | BSE | SELL | 31944 | 3.52 |
19-07-2017 | TULSA NETRAPRASHAD SILWAL | BSE | SELL | 50000 | 3.53 |
18-07-2017 | TULSA NETRAPRASHAD SILWAL | BSE | SELL | 47815 | 3.53 |
30-05-2017 | ROJANALA SATYANARAYANA | BSE | SELL | 46800 | 2.34 |
30-05-2017 | KARTIK SUNIL JAIN | BSE | SELL | 10 | 2.34 |
30-05-2017 | KARTIK SUNIL JAIN | BSE | BUY | 30000 | 2.34 |
20-04-2017 | AMITKUMAR VALABHAI PATEL | BSE | SELL | 32000 | 1.75 |
28-03-2017 | KARAN SUNIL JAIN | BSE | BUY | 50908 | 1.37 |
28-03-2017 | VIPUL BHAGWANDAS SHAH | BSE | SELL | 50000 | 1.37 |
27-03-2017 | SHRIRAM CREDIT COMPANY LIMITED | BSE | SELL | 39954 | 1.37 |
23-03-2017 | VIJAYBHAI V DOSHI | BSE | BUY | 35000 | 1.37 |
23-03-2017 | SHRIRAM CREDIT COMPANY LIMITED | BSE | SELL | 50000 | 1.37 |
22-03-2017 | SHRIRAM CREDIT COMPANY LIMITED | BSE | SELL | 50000 | 1.37 |
17-03-2017 | SHRIRAM CREDIT COMPANY LIMITED | BSE | SELL | 46660 | 1.41 |
17-03-2017 | KUNAL JAIN | BSE | BUY | 43000 | 1.41 |
16-03-2017 | SHRIRAM C | BSE | SELL | 45050 | 1.43 |
16-03-2017 | KUNAL JA | BSE | BUY | 35000 | 1.43 |
15-03-2017 | SHRIRAM CREDIT COMPANY LIMITED | BSE | SELL | 40000 | 1.45 |
14-03-2017 | SHRIRAM CREDIT COMPANY LIMITED | BSE | SELL | 35076 | 1.47 |
03-10-2012 | K R KARTHIKEYAN | BSE | BUY | 47000 | 2.11 |
Quick Links for Rubra Medicaments:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices